In this letter we inform you about upcoming changes in our product portfolio in 2024.
In Autumn 2023, Immuno Diagnostic Oy has undergone co-operation negotiations which results in changes both in our personnel and the products and solutions we represent. As a consequence, the number of our Life Science suppliers will be significantly reduced and in the future we are focusing on selected manufacturers. Many well-known suppliers shall still remain in our portfolio, and the changes are not affecting our diagnostics, microscopy and pathology product lines. These changes will take place starting from 1.1.2024, and we will regularly update the list of suppliers on our website.
We encourage you to contact our customer service (firstname.lastname@example.org) if you require more information. We shall do our best to help you during this time of change and Immuno Diagnostic Oy continues to operate as the local support of its customers. Our aim and goal is to bring new products and state-of-the-art innovations to the market to advance diagnostics and research in Finland.
The list of suppliers with whom our co-operation will end:
Abnova, ACROBiosystems, AdipoGen Life Sciences, Alpha Diagnostic International, BioAssay Systems, Bioss, Biotools, Boster Bio, Cayman Chemical, Cloud-Clone, Creative Biolabs, Creative Biomart, Creative Diagnostics, Creative Enzymes, ECM Biosciences, Flomics, Geneaid, Health in Code, ImmunoChemistry Technologies, Immunostep, Invent Biotechnologies, Metabion, Mirus bio, PAN-Biotech, REPROCELL, Ritter GmbH, ScienCell Research Laboratories, Tecan Genomics (Nugen), TelesisBio and US Biologicals.
All products are available from us until the end of year 2023 and for some suppliers co-operation continues a little longer.